期刊文献+

重组腺相关病毒质量控制的qPCR技术研究进展 被引量:4

Advances in Real-Time Quantitative PCR Technology for Quality Control of Recombinant Adeno-Associated Virus
下载PDF
导出
摘要 综述实时荧光定量PCR(qPCR)技术在重组腺相关病毒(rAAV)的基因组滴度测定中的应用成果,以及qPCR技术在rAAV质量控制过程中的应用,如感染滴度及rcAAV污染率的测定等.分析qPCR技术存在的适用范围窄、易产生系统性误差和易受rAAV杂质干扰等问题的原因,并探讨相关的解决策略. This paper reviews the application achievement of real-time quantitative PCR (qPCR) technology in the re- combinant adeno-associated virus genome titer determination and its application in rAAVs' quality control, including in- fectious titer and contamination rate of reAAV. The current several problems of qPCR technique, such as relatively nar- row application range, easy to cause systemic errors and be interfered by rAAV impurity, are analyzed and discussed on better countermeasures.
出处 《华侨大学学报(自然科学版)》 CAS 北大核心 2014年第2期191-195,共5页 Journal of Huaqiao University(Natural Science)
基金 国家自然科学基金资助项目(81371669 81271691) 国家国际科技合作项目(2011DFG33320)
关键词 重组腺相关病毒 基因组滴度 实时荧光定量PCR 基因治疗 recombinant adeno-associated virus genome titratiom real-time quantitative PCR gene therapy
  • 相关文献

参考文献34

  • 1BAINBRIDGE J W B,SMITH A J,BARKER S S,et al.Effect of gene therapy on visual function in Leber’s congenital amaurosis[J].N Engl J Med,2008,358(21):2240-2248.
  • 2MAGUIRE A M, HIGH K A,AURICCHIO A,et al.Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: A phase1 dose-escalation trial[J].Lancet,2009,374(9701):1597-1605.
  • 3MAGUIRE A M,SIMONELLI F,PIERCE E A,et al.Safety and efficacy of gene transfer for Leber’s congenital amaurosis[J].N Engl J Med,2008,358(21):2240-2248.
  • 4VELDWIJK M R,SCHIEDLMEIER B,KLEINSCHMIDT J A,et al.Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helper virus-free adeno-associated viral vector stocks[J].Eur J Cancer,1999,35(7):1136-1142.
  • 5GRIMM D,KERN A,PAWLITA M,et al.Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2[J].Gene Therapy,1999,6(7):1322-1330.
  • 6SUMMERFORD C,SAMULSKI,R J.Viral receptors and vector purification: New approaches for generating clinical-grade reagents[J].Nat Med,1999,5:587-588.
  • 7SALVETTI A,ORèVE S,CHADEUF G,et al.Factors influencing recombinant adeno-associated virus production[J].Hum Gene Ther,1998,9(5):695-706.
  • 8刁勇,马健,李欣燕,孙学英,许瑞安.表达血管抑制因子的腺相关病毒载体的构建及其体内外活性[J].生物工程学报,2008,24(11):1949-1954. 被引量:8
  • 9VELDVIJK M R,TOPALY J,LAUFS S,et al.Development and optimization of a real- time quantitative PCR-based method for the titration of AAV-2vector stocks[J].Mol Ther,2002,6(2):272-278.
  • 10AURNHAMMER C,HAASE M,MUETHER N,et al.Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences[J].Hum Gene Ther Methods,2012,23(1):18-28.

二级参考文献33

  • 1陈迁,李子博,曾赵军,罗赛群,胡维新.Tet-On调控HSVtk表达的重组腺相关病毒载体的构建和感染活性的检测[J].生物工程学报,2005,21(3):360-364. 被引量:6
  • 2Pike SE, Yao L, Jones KD, et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med, 1998, 188(12): 2349-2356.
  • 3Pike SE, Yao L, Setsuda J, et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood, 1999, 94(7): 2461-2468.
  • 4I Xiao F, Wei Y, Yang L, et al. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Ther, 2002, 9(18): 1207-1213.
  • 5Li L, Yuan YZ, Lu J, et al. Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice. Gut, 2006, 55(2): 259-265.
  • 6Liu MH, Imam H, Oberg K, et al. Gene transfer of Vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior. Neuroendocrinology, 2005, 82(1): 1-10.
  • 7Okada F, Rakj J, Croix BT, et al. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factoryvascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA, 1998, 95(7): 3609-3614.
  • 8Nathwani AC,Tuddenham EG,Rangarajan S. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B[J].New England Journal of Medicine,2011,(25):2357-2365.
  • 9Decressac M,Mattsson B,Lundblad M. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synucle in in midbrain dopamine neurons[J].Neurobiology of Disease,2012,(03):939-953.
  • 10Mandel RJ. CERE-110,an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease[J].Current Opinion in Molecular Therapeutics,2010,(02):240-247.

共引文献9

同被引文献11

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部